Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

This study has been completed.
Information provided by:
Solvay Pharmaceuticals Identifier:
First received: March 21, 2008
Last updated: April 1, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)